CONMED Corp — Director's Dealing 2015

Jul 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-07-02

Reporting Person: Farkas Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-02	Common Stock	P	205	$58.6552	Acquired	3440	Direct

Footnotes

F1: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/27/15.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.64 to $58.67. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.